Karyopharm Presents Positive Selinexor Data from the Phase 1b/2 STOMP Study at the American Society of Hematology 2017 Annual Meeting
Go back to Karyopharm Presents Positive Selinexor Data from the Phase 1b/2 STOMP Study at the American Society of Hematology 2017 Annual Meeting| KARYOPHARM THERAP (NASDAQ: KPTI) | Delayed: 7.18 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.18 | 52 Week High | $19.41 | |||
| Open | $7.18 | 52 Week Low | $4.83 | |||
| Day High | $7.18 | P/E | N/A | |||
| Day Low | $7.18 | EPS | $-2.74 | |||
| Volume | 563 | |||||
